CLASS II ONGOING Device recall · Reported 23 Mar 2022 · FDA Enforcement Report

Jagtome Revolution RX 39-30-260-025 Material Number: M00584260 recalled

Boston Scientific is recalling Jagtome Revolution RX 39-30-260-025 Material Number: M00584260, distributed nationwide in the US. The recall was initiated on 22 Dec 2021 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot Numbers: Batch 27482863 27532553 27602969 27652583 27723139 27758892 27796835 27846707 27899139 27966498 28021411 GTIN: 8714729953258
Quantity recalled3330 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0767-2022
FDA event ID
89468
Recalling firm
Boston Scientific, Marlborough, MA
Classification
Class II
Status
Ongoing
Recall initiated
22 Dec 2021
FDA classified
11 Mar 2022
Reported
23 Mar 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

22 Dec 2021Recall initiated by company
11 Mar 2022Classified by FDA+79 days
23 Mar 2022Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Sterility of device is compromised due to a sterile barrier breach

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

JAGTOME REVOLUTION RX 39-30-260-025 Material Number: M00584260

Where it was distributed

Worldwide distribution - US Nationwide and the countries of Australia, Austria, Belgium, Canada, Botswana, China, Czech Republic, Denmark, Finland, France, Germany, Great Britain, Greece, Ireland, Italy, Japan, Korea, Kuwait, Latvia, Lebanon, Mauritius, Morocco, Namibia, Netherlands, New Zealand, Norway, Poland, Portugal, Qatar, Romania, Russian Fed., Saudi Arabia, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Unit. Arab Emir.

Nationwide

Questions about this recall

Is Jagtome Revolution RX 39-30-260-025 Material Number: M00584260 recalled?

Yes. Boston Scientific recalled Jagtome Revolution RX 39-30-260-025 Material Number: M00584260 on 22 Dec 2021. The recall is Class II and its status is Ongoing. Recall number Z-0767-2022.

Why was it recalled?

Sterility of device is compromised due to a sterile barrier breach

Which lots are affected?

Lot Numbers: Batch 27482863 27532553 27602969 27652583 27723139 27758892 27796835 27846707 27899139 27966498 28021411 GTIN: 8714729953258

Where was it sold?

Worldwide distribution - US Nationwide and the countries of Australia, Austria, Belgium, Canada, Botswana, China, Czech Republic, Denmark, Finland, France, Germany, Great Britain, Greece, Ireland, Italy, Japan, Korea, Kuwait, Latvia, Lebanon, Mauritius, Morocco, Namibia, Netherlands, New Zealand, Norway, Poland, Portugal, Qatar, Romania, Russian Fed., Saudi Arabia, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Unit. Arab Emir.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Boston Scientific

All 626

Other Other Medical Devices recalls

All 13,778